Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer (Q47786985)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer |
scientific article published in May 2004 |
Statements
1 reference
Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer (English)
1 reference
Yoo-Joung Ko
1 reference
Glenn J Bubley
1 reference
Robert Weber
1 reference
Charles Redfern
1 reference
Daniel P Gold
1 reference
Lothar Finke
1 reference
Andreas Kovar
1 reference
Thomas Dahl
1 reference
Stephen D Gillies
1 reference
1 May 2004
1 reference
27
1 reference
3
1 reference
232-239
1 reference